AstraZeneca sells drug for $70 million as divestment drive continues

LONDON (Reuters) - AstraZeneca has sold rights to a non-core drug to a unit of Kyowa Hakko Kirin for an upfront payment of $70 million, a day after getting $500 million for two ageing heart medicines.

http://ift.tt/1QReJL0

from Reuters: Health News
via animenewspro